Related Experiment Video
Updated: Mar 9, 2026
05:28
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
3.8K
Oral, Slow-Release Ivermectin: Biting Back at Malaria Vectors.
Carlos J Chaccour1, N Regina Rabinovich2
1ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Instituto de Salud Tropical Universidad de Navarra, Pamplona, Spain.
Trends in Parasitology
|January 10, 2017
Summary
A new formulation releases the mosquito-killing drug ivermectin for 10 days after one dose. This malaria control strategy could significantly reduce mosquito populations and aid elimination efforts.
Area of Science:
- Medical Entomology
- Parasitology
- Drug Delivery Systems
Background:
- Malaria remains a significant global health burden, necessitating innovative vector control strategies.
- Current interventions face challenges with resistance and adherence.
- Targeting mosquito vectors directly is crucial for malaria elimination.
Purpose of the Study:
- To evaluate a novel oral formulation designed for sustained release of ivermectin.
- To assess the potential of this formulation as a tool for malaria vector control.
Main Methods:
- Development of an oral drug formulation for sustained ivermectin release.
- In vitro or in vivo studies to determine the duration of drug release and efficacy.
Main Results:
- The formulation successfully released ivermectin for a 10-day period after a single oral administration.
- This sustained release has the potential to reduce the survival and reproductive capacity of mosquito vectors.
Conclusions:
- This ivermectin formulation represents a promising new tool for malaria control.
- Sustained-release ivermectin could complement existing strategies, potentially accelerating malaria elimination efforts.
